Australia's largest stock trading and investment forum Australia's #1 stock forum

TBR

Click for more information

1.97%

$4.67 tribune resources limited

Ann: Half Yearly Report and Accounts, page-19

First 19 Last

Share
Profile

Follow
long_haul

452 Posts.

54

15/04/24

21:57

Post #: 73357472
Share

Originally posted by jogo: ↑

And yet, it is as though the bullion holdings are hidden from investors. They have to dig into the annual accounts to find these and they are consistently excluded from the cash and equivalents in quarterly reports.
Clearly, the controlling shareholder(s) assign no value to retail holders but expect them to be satisfied with a depressed SP in the face of a surging POG and a dividend yield that is admittedly above the norm for gold producers.
As evidence of the disregard for other shareholders, just look at the SP performance in the chart below over a period when the POG has been holding its own, and then increasing, whereas only lately has the SP responded. Even so, it is so very much behind the POG increase.

As for Ghana and The Philippines, it is as though these do not exist

Expand

Whilst I agree with you on the opaque reporting style, the share price reaction (or lack thereof) as it relates to gold is not unique to TBR. The charts of other gold producers on the aSX are very similar. As examples, two others that I own in WAF and RSG, have both moved in a similar fashion. So I don't think any blame can be caste upon management in that department as it's beyond their control.

Last edited by long_haul: 15/04/24

TBR Price at posting: $4.49 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 6 more messages in this thread...

First 19 Last

Add TBR (ASX) to my watchlist

(20min delay)
Last $4.67		Change 0.090(1.97%)		Mkt cap ! $243.4M

Open	High	Low	Value	Volume
$4.63	$4.67	$4.63	$23.39K	5.01K

Buyers (Bids)

No.	Vol.	Price($)
1	1	$4.62

Sellers (Offers)

Price($)	Vol.	No.
$4.74	2905	1

View Market Depth

No.	Vol.	Price($)
1	5000	4.670
1	1	4.620
1	1	4.600
1	1	4.580
1	1	4.560

Price($)	Vol.	No.
4.740	2905	1
4.750	5175	2
4.820	820	1
4.930	2470	1
5.010	120	1

Last trade - 11.08am 07/10/2024 (20 minute delay)

TBR (ASX) Chart